Document:

EXHIBIT
B TO SECURITIES PURCHASE AGREEMENT

 

THE
SECURITIES REPRESENTED HEREBY, INCLUDING THE SHARES ISSUABLE UPON EXERCISE HEREOF, HAVE NOT BEEN REGISTERED UNDER THE SECURITIES
ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS AND NEITHER THE SECURITIES NOR ANY INTEREST THEREIN MAY BE OFFERED, SOLD,
TRANSFERRED, PLEDGED OR OTHERWISE DISPOSED OF EXCEPT PURSUANT TO AN EFFECTIVE REGISTRATION STATEMENT UNDER SUCH ACT OR SUCH LAWS
OR AN EXEMPTION FROM REGISTRATION UNDER SUCH ACT AND SUCH LAWS WHICH, IN THE OPINION OF COUNSEL FOR THE ISSUER, IS AVAILABLE.

 

SERIES
A WARRANT AGREEMENT

 

No.
___

 

eWellness
HEALTHCARE Corporation

 

This
Warrant Agreement (this “Agreement”) is dated as of October [ ], 2014 (the “Issue Date”)
and entered into by and between eWellness Healthcare Corporation, a company organized under the laws of State of Nevada and ________________,
(together with its successors and assigns, the “Warrant Holder”).

 

WHEREAS,
[on the date hereof], the Company and the Warrant Holder entered into that certain Securities Purchase Agreement of even date
herewith (the “Purchase Agreement”), pursuant to which, the Warrant Holder, together with the other Purchasers
agreed to purchase certain Securities of the Company, including the Warrants evidenced by this Agreement;

 

WHEREAS,
any words not specifically defined herein, shall have the meaning set forth in the Purchase Agreement;

 

NOW,
THEREFORE, in consideration of the mutual covenants set forth in this Agreement and for other good and valuable consideration,
the parties agree as follows:

 

1. Grant
of Warrant. The Company hereby, upon the terms and subject
to the conditions of this Agreement, issues to the Warrant Holder a warrant (the “Warrant”) evidenced by this
Agreement to purchase up to [________] shares of Common Stock (the shares of Common Stock issuable to the Warrant Holder hereunder
(as such amount may be adjusted pursuant to the terms hereof), the “Warrant Shares”) at an exercise price of
$0.35 per share (as such amount may be adjusted pursuant to the terms hereof, the “Exercise Price”). The Exercise
Price and the number of Warrant Shares for which the Warrant are exercisable shall be subject to adjustment as described in Section
6.

 

2. Term
and Termination of Warrant. The Warrant shall terminate
on the third (3rd) anniversary of the Issue Date (the “Expiration Date”).

 

    	 

    	 

    

 

3. Exercise
of the Warrant.

 

(a)Exercise
and Payment. The purchase rights represented by the Warrant may be exercised by the Warrant Holder, in whole or in part at
any time following the the date on which the Commission declares the Registration Statement effective (the “Exercise Event
Date”), and at any time prior to the Expiration Date, the Holder may exercise this Warrant into shares of the Company’s
Common Stock, by the surrender of the Warrant (together with a duly executed notice of exercise in the form attached hereto as
Exhibit A) at the principal office of the Company, and by the payment to the Company, at the option of the Warrant Holder
by:

 

(i)wire
transfer of immediately available funds, of an amount equal to (A) the number of shares of Common Stock being purchased upon exercise
of the Warrant multiplied by (B) the then current Exercise Price (the “Warrant Price”);

 

(ii)If
at any time after a date which shall be one hundred and eighty (180) days after the Exercise Effective Date, there is no effective
registration statement registering, or no current prospectus available for, the resale of the Warrant Shares by the Warrant Holder,
then this Warrant may also be exercised, in whole or in part, at such time by means of a “cashless exercise”, wherein
the Warrant Holder may surrender to the Company that number of Warrant Shares (or the right to receive such number of shares)
having an aggregate Fair Market Value at such time equal to or greater than the Warrant Price for all shares then being purchased
(including those being surrendered); or

 

(iii)any
combination thereof.

 

For
purposes of this Agreement, “Fair Market Value” of a share as of a particular date shall mean: (A) if the Common
Stock is traded on an exchange or the over-the-counter market or otherwise quoted or reported on a national exchange, the average
reported closing price for the five (5) trading days prior to the date of determination of fair market value, (B) if conversion
or exercise is simultaneous with an underwritten public offering of Common Stock registered under the Securities Act of 1933,
as amended, then the initial public offering price (before deducting commissions, discounts or expenses) per share sold in such
offer, and (C) otherwise that price determined in good faith and in such reasonable manner as prescribed by a majority of the
Board.

 

(b)Stock
Certificates. In the event of the exercise of all or any portion of the Warrant, certificates for the Warrant Shares so purchased
shall be delivered to the Warrant Holder by the Company at the Company’s own expense within a reasonable time, which shall
in no event be later than five (5) days thereafter and, unless the Warrant has been fully exercised or has expired, a new Warrant
representing the Warrant Shares with respect to which the Warrant shall not have been exercised shall be issued to the Warrant
Holder within such time.

 

(c)Fractional
Warrant Shares. No fractional Warrant Shares will be issued in connection with any exercise hereunder, but instead the shares
shall be rounded up to the nearest whole share.

 

    	2

    	 

    

 

(d)Ownership
Limitation. Notwithstanding the provisions of this Warrant, in no event shall this Warrant be exercisable to the extent that
the issuance of Common Stock upon the exercise hereof, after taking into account the Common Stock then owned by the Warrant Holder
and its affiliates, would result in the beneficial ownership by the Warrant Holder and its affiliates of more than 4.99% of the
outstanding Common Stock of the Company. For purposes of this paragraph, beneficial ownership shall be determined in accordance
with Section 13(d) of the Securities Exchange Act of 1934, as amended.

 

(e)Call
Provision. Subject to the provisions of Section 3(d) and this Section 3(e), in the event the Common Stock shall be listed
on a U.S. stock exchange and trade, as determined by the daily closing price, for twenty (20) consecutive trading days at or above
$1.50 per share (the “Redemption Event”), the Company shall have the right, but not the obligation, to redeem all
or any portion of the outstanding Warrant, at which time the Holder may elect to exercise the Warrant as set forth in Section
3(a) above. No later than ten (10) Business Days following a Redemption Event, the Company shall deliver written notice thereof
via facsimile to the Holder (a “Redemption Notice”). At any time during the period beginning after the
date of the Redemption Notice and ending five (5) Business Days thereafter, the Holder may submit an Exercise Notice to the Company
requesting to exercise all or any portion of this Warrant (“Redemption Exercise Notice”), to the Company, which
Redemption Exercise Notice shall indicate the portion of the Warrant the Holder is electing to exercise. The Company shall redeem
the then outstanding portion of the Warrant, if any, on the twentieth (20th) Business Day following the date of the Redemption
Notice at the Exercise Price, in cash or in shares of Common stock, at the Company’s sole discretion. The payment in cash
for any redemptions shall be in compliance with Rule 419 of the Securities Act. Notwithstanding the foregoing, the Company may
only redeem the Warrants in shares of Common Stock if from the date the Holder receives the Redemption Notice through and until
the date such redemption is paid in full, the Equity Conditions have been satisfied, unless waived in writing by the Holder. For
purposes of this Article III, Equity Conditions shall mean during the period in question, (a) the Company shall have duly honored
all exercises and redemptions scheduled to occur or occurring by virtue of one or more Notices of Exercise of the Holder, if any,
(b) the Company shall have paid all other amounts owing to the Holder in respect of this Note, if any, (c)(i) there is an effective
registration statement pursuant to which the Holder is permitted to utilize the prospectus thereunder to resell all of the shares
of Warrant Shares (and the Company believes, in good faith, that such effectiveness will continue uninterrupted for the foreseeable
future) or (ii) all of the Warrant Shares (and shares issuable in lieu of cash payments of interest) may be resold pursuant to
Rule 144 without volume or manner-of-sale restrictions or current public information requirements as determined by the counsel
to the Company as set forth in a written opinion letter to such effect, addressed and acceptable to the Holder, (d) the Common
Stock is trading on a Trading Market and all of the Warrant Shares are listed or quoted for trading on such Trading Market (and
the Company believes, in good faith, that trading of the Common Stock on a Trading Market will continue uninterrupted for the
foreseeable future), (e) there is a sufficient number of authorized but unissued and otherwise unreserved shares of Common Stock
for the issuance of all of the shares then issuable pursuant to the Warrant, (f) there is no existing Event of Default and no
existing event which, with the passage of time or the giving of notice, would constitute an Event of Default, (g) there has been
no public announcement of a pending or proposed Change of Control Transaction that has not been consummated and (h) the Holder
is not in possession of any information provided by the Company that constitutes, or may constitute, material non-public information.
The Company’s right to call the Warrants under this Section 3(e) shall be exercised ratably among the Holders based on each
Holder’s initial purchase of Warrants.

 

    	3

    	 

    

 

4. Stock
Fully Paid; Reservation of Warrant Shares. All of the Warrant
Shares issuable upon the exercise of the Warrant will, upon issuance and receipt of the Warrant Price for such Warrant Shares,
be duly authorized, validly issued, fully paid and nonassessable, and will be free and clear of all taxes, liens, encumbrances
and charges with respect to the issue.

 

5. Rights
of the Warrant Holder. The Warrant Holder shall have no
voting rights as a stockholder or rights to dividends or other distributions with respect to Warrant Shares subject to this Agreement
until payment in full of the Warrant Price for Warrant Shares being issued.

 

6. Adjustment
of Exercise Price and Number of Warrant Shares. The
Exercise Price and the number of Warrant Shares purchasable upon any exercise of the Warrant shall be subject to adjustment
from time to time upon the occurrence of certain events described in this Section 6.

 

(a)Subdivision
or Combination of Stock; Stock Dividend and Stock Conversion.

 

(i)In
the event the Company should at any time or from time to time fix a record date for the effectuation of a split or subdivision
of the outstanding shares of Common Stock, or a record date for the determination of the holders of capital stock entitled to
receive a dividend or other distribution payable in Common Stock or other securities or rights convertible into, or rights that
entitle the holders of Common Stock to purchase, Common Stock (hereinafter referred to as “Common Stock Equivalents”),
without payment of any consideration by such holders for the additional Common Stock or the Common Stock Equivalents (including
the additional Common Stock issuable upon conversion or exercise thereof), then, as of such record date (or the date of such dividend
distribution, split or subdivision if no record date is fixed), (y) the Exercise Price of the Warrant Shares shall be appropriately
decreased (but not below the then par value per share of Common Stock), or (z) the number of Warrant Shares shall be increased
in proportion to such increase of outstanding Common Stock and shares of Common Stock issuable with respect to Common Stock Equivalents.

 

(ii)If
the number of shares of Common Stock outstanding at any time after the Issue Date is decreased by a combination of the outstanding
Common Stock, then, upon the record date of such combination, (A) the Exercise Price shall be appropriately increased, or (B)
the number of Warrant Shares shall be decreased in proportion to such decrease in outstanding Common Stock.

 

(iii)The
Company will not modify its certificate of incorporation or effect any reorganization, recapitalization, transfer of assets, consolidation,
merger, dissolution, issue or sale of securities in a manner that negates or avoids the rights of the Warrant Holder to exercise
its rights hereunder, but will at all times assist in the carrying out of all the provisions of this Agreement and in the taking
of all such actions as may be necessary or appropriate in order to protect the Warrant Holder against impairment.

 

    	4

    	 

    

 

(iv)The
foregoing provisions of Section 6(a) shall not apply with regard to: (i) shares of Common Stock or standard options to
purchase Common Stock to directors, officers or employees of the Company in their capacity as such pursuant to a board approved
stock option plan; (ii) shares of Common Stock issued upon the conversion or exercise of Common Stock Equivalents (other than
standard options to purchase Common Stock that are covered by clause (i) above) issued prior to the Issue Date, provided that
the conversion or exercise (as the case may be) of any such Convertible Security is made solely pursuant to the conversion or
exercise (as the case may be) provisions of such Convertible Security that were in effect on the date immediately prior to the
Issue Date, the conversion or exercise price of any such Convertible Securities (other than standard options to purchase Common
Stock covered by clause (i) above) is not lowered, none of such Convertible Securities are (other than standard options to purchase
Common Stock covered by clause (i) above) (nor is any provision of any such Convertible Securities) amended or waived in any manner
(whether by the Company or the holder thereof) to increase the number of shares issuable thereunder and none of the terms or conditions
of any such Convertible Securities (other than standard options to purchase Common Stock covered by clause (i) above) are otherwise
materially changed or waived (whether by the Company or the holder thereof) in any manner that adversely affects the Holder; (iii)
the Notes; (iv) the Notes Shares; and (v) shares of Common Stock in connection with mergers, acquisitions, strategic licensing
arrangements, strategic business partnerships or joint ventures, in each case with non-affiliated third parties and otherwise
on an arm’s-length basis, the purpose of which is not to raise additional capital. 

 

(b)Notice
of Adjustment. Promptly after adjustment of the Exercise Price or any increase or decrease in the number of shares purchasable
upon the exercise of the Warrant, the Company shall give written notice in accordance with Section 11. The notice shall
be signed by an authorized officer of the Company and shall state the effective date of the adjustment and the Exercise Price
resulting from such adjustment and the increase or decrease, if any, in the number of shares purchasable at such price upon any
exercise of the Warrant, setting forth in reasonable detail the method of calculation and the facts upon which such calculation
is based.

 

(c)Other
Notices. In the event that the Company shall propose at any time: (i) to declare any dividend or distribution upon any class
or series of capital stock, whether in cash, property, stock or other securities (including, without limitation, pursuant to a
split or subdivision of the outstanding shares of capital stock); (ii) to effect any reclassification or recapitalization of its
capital stock outstanding involving a change in the capital stock; or (iii) to merge or consolidate with or into any other corporation,
or to sell, lease or convey all or substantially all of its property or business, or to liquidate, dissolve or wind up; then,
in connection with each such event, the Company shall mail to the Warrant Holder notice of such transaction:

 

    	5

    	 

    

 

(A)at
least five (5) business days’ prior written notice in accordance with Section 11 of the date on which a record shall
be taken for such dividend or distribution (and specifying the date on which the holder of the affected class or series of capital
stock shall be entitled thereto) or for determining the rights to vote, if any, in respect of the matters referred to in (c)(ii)
and (c)(iii) above; and

 

(B)in
the case of the matters referred to in (c)(ii) and (c)(iii) above, written notice of such impending transaction not later than
ten (10) business days’ prior to any shareholders’ meeting called to approve such transaction, or ten (10) business
days’ prior to the closing of such transaction, whichever is earlier, and shall also notify the Warrant Holder in writing
in accordance with Section 11 of the final approval of such transaction by the stockholders of the Company (if such approval
is required). The first of such notices shall describe the terms and conditions of the impending transaction that are material
to a holder of Common Stock (as determined by the Board of Directors of the Company (the “Board”) in good faith)
and specify the date on which a holder of Common Stock shall be entitled to exchange his, her or its Common Stock for securities
or other property deliverable upon the occurrence of such event) and the Company shall thereafter give such holder prompt notice
of any changes in such terms or conditions that are material to a holder of Common Stock (as determined by the Board in good faith).
The Company acknowledges that any record date must be set at a date that would permit the Warrant Holder effectively to exercise
its rights hereunder.

 

(d)Changes
in Stock. In case at any time prior to the Expiration Date, the Company shall be a party to any transaction (including, without
limitation, a merger, consolidation, sale of all or substantially all of the Company’s assets or recapitalization of its
capital stock) in which the previously outstanding shares of Common Stock shall be changed into or exchanged for different securities
of the Company or common stock or other securities of another corporation or interests in a noncorporate entity or other property
(including cash) or the Company shall make a distribution on its shares of Common Stock, other than regular cash dividends on
its outstanding stock, or any combination of any of the foregoing (each such transaction being herein called the “Transaction”
and the date of consummation of the Transaction being herein called the “Consummation Date”), then as a condition
of the consummation of such Transaction, lawful and adequate provisions shall be made so that the Warrant Holder, upon the exercise
hereof at any time on or after the Consummation Date and prior to the Expiration Date, shall be entitled to receive, and this
Agreement shall thereafter represent the right to receive, in lieu of the Warrant Shares issuable upon such exercise prior
to the Consummation Date, the highest amount of securities or other property to which the Warrant Holder would actually have been
entitled as a stockholder upon the consummation of the Transaction if the Warrant Holder had exercised the Warrant immediately
prior thereto. The provisions of this Section 6(d) shall similarly apply to successive Transactions.

 

7. Taxes.
The Warrant Holder acknowledges that upon exercise of the Warrant the Warrant Holder may be deemed to have taxable income in respect
of the Warrant and/or the Warrant Shares. The Warrant Holder acknowledges that any income or other taxes due from it with respect
to the Warrant or the Warrant Shares issuable pursuant to the Warrant shall be the Warrant Holder’s responsibility.

 

8. Reservation
of Warrant Shares. From and after the Issue Date, the Company
shall at all times reserve and keep available for issue upon exercise of this Warrant such number of its authorized but unissued
shares of Common Stock as will be sufficient to permit the exercise in full of this Warrant.

 

    	6

    	 

    

 

9. Registration
Rights. Subject
to Section 3(a)(2) above, the initial Holder of this Warrant (and certain assignees thereof) is entitled to the benefit of such
registration rights in respect of the Warrant Shares as are set forth in the Registration Rights Agreement dated as of [ ] by
and among the Company and the investors listed on the execution page thereof (the “Registration
Rights Agreement”)

 

10. Representations
and Warranties.

 

(a)Representations
and Warranties by the Company. The representations and warranties of the Company set forth in Section 3.1 of the Purchase
Agreement are true and correct as of the Issue Date.

 

(b)Representations
and Warranties by the Warrant Holder. The representations and warranties of the Warrant Holder set forth in Section 3.2 of
the Purchase Agreement are true and correct as of the Issue Date.

 

11. Registration
Rights. The Company acknowledges that the Warrant
Shares are subject to the registration rights set forth in the Purchase Agreement.

 

12. Transfer
Restrictions.

 

(a)Legend.
The Securities to be acquired by the Holder pursuant hereto, may not be sold or transferred unless (A) such shares are sold
pursuant to an effective registration statement under the Securities Act, or (B) the Company or its transfer agent shall have
been furnished with an opinion of counsel (which opinion shall be in form, substance and scope customary for opinions of counsel
in comparable transactions) to the effect that the shares to be sold or transferred may be sold or transferred pursuant to an
exemption from such registration or (C) such shares are sold or transferred pursuant to Rule 144 under the Securities Act (or
a successor rule) (“Rule 144”) or (D) such shares are sold or transferred outside the United States in accordance
with Rule 904 of Regulation S under the Securities Act, or (E) such shares are transferred to an “affiliate” (as defined
in Rule 144) of the Company who agrees to sell or otherwise transfer the shares only in accordance with this Section 11. Except
as otherwise provided in this Warrant (and subject to the removal provisions set forth below), until such time as the Securities
issuable upon exercise of the Holder’s Warrant have been registered under the Act, otherwise may be sold pursuant to Rule
144 without any restriction as to the number of securities as of a particular date that can then be immediately sold, each certificate
for shares of the Securities that has not been so included in an effective registration statement or that has not been sold pursuant
to an effective registration statement or an exemption that permits removal of the legend, shall bear a legend substantially in
the following form, as appropriate:

 

    	7

    	 

    

 

THE
SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE UNITED STATES SECURITIES ACT OF 1933, AS AMENDED (THE “U.S.
SECURITIES ACT”). THE HOLDER HEREOF, BY PURCHASING SUCH SECURITIES, AGREES THAT SUCH SECURITIES MAY BE OFFERED, SOLD, PLEDGED
OR OTHERWISE TRANSFERRED ONLY (A) TO THE CORPORATION, (B) OUTSIDE THE UNITED STATES IN ACCORDANCE WITH RULE 904 OF REGULATION
S UNDER THE U.S. SECURITIES ACT, (C) WITHIN THE UNITED STATES AFTER REGISTRATION OR IN ACCORDANCE WITH THE EXEMPTION FROM THE
REGISTRATION REQUIREMENTS UNDER THE U.S. SECURITIES ACT PROVIDED BY RULE 144 THEREUNDER, IF APPLICABLE, AND IN ACCORDANCE WITH
APPLICABLE STATE SECURITIES LAWS, OR (D) WITHIN THE UNITED STATES IN A TRANSACTION THAT DOES NOT REQUIRE REGISTRATION UNDER THE
U.S. SECURITIES ACT OR ANY APPLICABLE STATE SECURITIES LAWS AND THE HOLDER HAS PRIOR TO SUCH SALE FURNISHED TO THE CORPORATION
AN OPINION OF COUNSEL REASONABLY SATISFACTORY TO THE CORPORATION.

 

(b)Removal
of Legend. The legend set forth above shall be removed and the Company shall issue to the Holder a new certificate therefor
free of any transfer legend if (A) the Company shall have received an opinion of counsel, in form, substance and scope customary
for opinions of counsel in comparable transactions, to the effect that a public sale or transfer of such Securities may be made
without registration under the Act and the shares are so sold or transferred, (B) such Holder provides the Company with reasonable
assurances that the Securities (to the extent such securities are deemed to have been acquired on the same date) can be sold pursuant
to Rule 144 or (C) in the case of the Common Stock issuable upon exercise of the Warrant, such security is registered for sale
by the Holder under an effective registration statement filed under the Act or otherwise may be sold pursuant to Rule 144 without
any restriction as to the number of securities as of a particular date that can then be immediately sold. The Company shall cause
its counsel to issue a legal opinion promptly after the effective date of any registration statement under the Act registering
the resale of the Common Stock issuable upon exercise of the Warrant if required to effect the removal of the legend hereunder.

 

13. Miscellaneous.
The terms of Article V of the Purchase Agreement are incorporated herein by reference as if set forth herein.

 

14. Assignability.
Notwithstanding Section 11 hereof, subject to the transfer and securities law restrictions set forth in this Agreement,
the Warrant Holder may assign, convey or transfer, in whole or in part, its rights under this Agreement and provide written notice
to Company of any such assignment, conveyance or transfer. Upon any transfer, assignment, pledge, hypothecation or other disposition
of the Warrant or of any rights granted hereunder in accordance with the terms of this Section 13, the Company shall if
necessary issue or re-issue warrant agreements reflecting the appropriate rights and entitlements of the Warrant Holder and any
transferee, assignee or pledgee after giving effect to such transfer, assignment or pledge.

 

[signatures
on following page]

 

    	8

    	 

    

 

IN
WITNESS WHEREOF, the undersigned hereby execute this Agreement as of the day and year first above written.

 

	 	COMPANY:
	 	 
	 	eWELLNESS HEALTHCARE CORPORATION
	 	 	 
	 	By:	 
	 	Name: 	Darwin Fogt
	 	Title: 	CEO

 

[Signature
Page – Warrant Agreement]

 

    	 

    	 

    

 

EXHIBIT
A

 

NOTICE
OF EXERCISE

 

	 	TO:	eWellness
                                         Healthcare Corporation

        11825
        Major Street

        Culver
        City, California

        Attn:

 

1.The
undersigned hereby elects to purchase _________ shares of Common Stock, par value $0.001 per share, of eWellness Healthcare Corporation
pursuant to the terms of the Warrant Agreement dated [ ], 2014, held by the undersigned, and tenders herewith payment of the purchase
price of such shares in full.

 

2.Please
issue a certificate or certificates representing said shares of Common Stock in the name of the undersigned or in such other name
as is specified below:

 

	 
	(Name)
	 
	 
	 
	 
	(Address)

 

	 	 
	 	(Signature)

 

	 	 	Title:	 
	 	 	 	 
	(Date)EXHIBIT
C TO SECURITIES PURCHASE AGREEMENT

 

REGISTRATION
RIGHTS AGREEMENT

 

This
Registration Rights Agreement (this “Agreement”) is made and entered into as of [  ], 2014 by and among eWellness
Healthcare Corporation, a Nevada corporation (the “Company”), and the purchasers listed on Schedule
I hereto (the “Purchasers”).

 

This
Agreement is being entered into pursuant to the Securities Purchase Agreement dated as of the date hereof among the Company and
the Purchasers (the “Purchase Agreement”).

 

The
Company and the Purchasers hereby agree as follows:

 

1. Definitions.

 

Capitalized
terms used and not otherwise defined herein shall have the meanings given such terms in the Purchase Agreement. As used in this
Agreement, the following terms shall have the following meanings:

 

“Advice”
shall have meaning set forth in Section 3(m).

 

“Affiliate”
means, with respect to any Person, any other Person which directly or indirectly through one or more intermediaries Controls,
is controlled by, or is under common control with, such Person. For the avoidance of doubt, with respect to a Purchaser which
is a general or limited partnership, an Affiliate shall be deemed to include affiliated partnerships managed by the same management
company or managing general partner or by an entity which controls, is controlled by, or is under common control with, such management
company or managing general partner.

 

“Board”
shall have meaning set forth in Section 3(n).

 

“Business
Day” means any day except Saturday, Sunday and any day which shall be a legal holiday or a day on which banking institutions
in the State of New York generally are authorized or required by law or other government actions to close.

 

“Closing
Date” means the date of the closing of the purchase and sale of the Notes pursuant to the Purchase Agreement.

 

“Commission”
means the Securities and Exchange Commission.

 

“Common
Stock” means the Company’s common stock, par value $0.001 per share.

 

“Control”
(including the terms “controlling”, “controlled by” or “under common control with”) means
the possession, direct or indirect, of the power to direct or cause the direction of the management and policies of a Person,
whether through the ownership of voting securities, by contract or otherwise.

 

    	 

    	 

    

 

“Diluted
Shares” means all of the shares of Common Stock underlying the Notes and the Warrants, including those issued upon conversion
of the Promissory Notes, and all of the Converted Offering Shares.

 

“Effectiveness
Date” means with respect to the Registration Statement under Section 2(a), the earlier of (A) the one hundred fiftieth
(150th) day following the later to occur of (i) the Closing Date or (ii) or in the event the Registration Statement
receives a “full review” by the Commission, the one hundred eightieth (180th) day) following the Closing
Date, or (B) the date which is within three (3) Business Days after the date on which the Commission informs the Company (i) that
the Commission will not review the Registration Statement or (ii) that the Company may request the acceleration of the
effectiveness of the Registration Statement; provided, however, that, if the Effectiveness Date falls on
a Saturday, Sunday or any other day which shall be a legal holiday or a day on which the Commission is authorized or required
by law or other government actions to close, the Effectiveness Date shall be the following Business Day.

 

“Effectiveness
Period” shall have the meaning set forth in Section 2(a).

 

“Event”
shall have the meaning set forth in Section 7(e).

 

“Event
Date” shall have the meaning set forth in Section 7(e).

 

“Exchange
Act” means the Securities Exchange Act of 1934, as amended.

 

“Filing
Date” means with respect to a Registration Statement under Section 2(a), the date that is the thirtieth (30th)
day following the the Closing Date; provided, however that if the Filing Date falls on a Saturday, Sunday or any
other day which shall be a legal holiday or a day on which the Commission is authorized or required by law or other government
actions to close, the Filing Date shall be the following Business Day.

 

“Holder”
or “Holders” means the holder or holders, as the case may be, from time to time of Registrable Securities.

 

“Indemnified
Party” shall have the meaning set forth in Section 5(c).

 

“Indemnifying
Party” shall have the meaning set forth in Section 5(c).

 

“Losses”
shall have the meaning set forth in Section 5(a).

 

“Notes”
means the convertible notes issued to the Purchasers pursuant to the Purchase Agreement.

 

    	 

    	 

    

 

“Offering”
means the offering made pursuant to Section 4(2) of the Securities Act and Rule 506 promulgated thereunder of Units of Securities
of the Company pursuant to the Purchase Agreement and the Private Placement Memorandum.

 

“Person”
means an individual or a corporation, partnership, trust, incorporated or unincorporated association, joint venture, limited liability
company, joint stock company, government (or an agency or political subdivision thereof) or other entity of any kind.

 

“Proceeding”
means an action, claim, suit, investigation or proceeding (including, without limitation, an investigation or partial proceeding,
such as a deposition), whether commenced or threatened.

 

“Prospectus”
means the prospectus included in the Registration Statement (including, without limitation, a prospectus that includes any information
previously omitted from a prospectus filed as part of an effective registration statement in reliance upon Rule 430A promulgated
under the Securities Act), as amended or supplemented by any prospectus supplement, with respect to the terms of the offering
of any portion of the Registrable Securities covered by the Registration Statement, and all other amendments and supplements to
the Prospectus, including post-effective amendments, and all material incorporated by reference in such Prospectus.

 

“Purchase
Agreement” means the Securities Purchase Agreement, dated as of [ ] between the Company and each of the Purchasers.

 

“Registrable
Securities” means, collectively (i) the Note Shares, the Warrant Shares, the Converted Offering Shares and the shares
of Common Stock issuable upon conversion of the Promissory Notes; (ii) any securities issued or issuable upon any stock split,
dividend or other distribution, recapitalization or similar event with respect to the foregoing; (iii) 400,000 shares issuable
to a consultant of the Company; (iv) 1,200,000 shares issuable to an investor pursuant to such investor’s $500,000 investment
into the Company; provided, that the Holder has completed and delivered to the Company a Selling Stockholder Questionnaire;
and provided, further, that the Note Share and Warrant Shares shall cease to be Registrable Securities upon the
earlier to occur of the following: (A) sale pursuant to a Registration Statement or Rule 144 under the Securities Act (in which
case, only such security sold shall cease to be a Registrable Security) or (B) becoming eligible for sale by the Holder pursuant
to Rule 144, without limitation.

 

“Registration
Statement” means a registration statement and any additional registration statements contemplated by Section 2, including
the Prospectus, amendments and supplements to such registration statement or Prospectus, including pre- and post-effective amendments,
all exhibits thereto, and all material incorporated by reference in such registration statement.

 

    	 

    	 

    

 

“Rule
144” means Rule 144 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended from time
to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same effect as such Rule.

 

“Rule
158” means Rule 158 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended from time
to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same effect as such Rule.

 

“Rule
415” means Rule 415 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended from time
to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same effect as such Rule.

 

“Rule
416” means Rule 416 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended from time
to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same effect as such Rule.

 

“Rule
424” means Rule 424 promulgated by the Commission pursuant to the Securities Act, as such Rule may be amended from time
to time, or any similar rule or regulation hereafter adopted by the Commission having substantially the same effect as such Rule.

 

“Securities
Act” means the Securities Act of 1933, as amended.

 

“SEC
Guidance” means (i) any publicly available written or oral guidance of the Commission staff, or any comments, requirements
or requests of the Commission staff and (ii) the Securities Act.

 

“Selling
Stockholder Questionnaire” means a questionnaire in the form attached as Exhibit B hereto, or such other form
of questionnaire as may reasonably be adopted by the Company from time to time.

 

“Warrants”
means the warrants to purchase shares of Common Stock issued to the Purchasers pursuant to the Purchase Agreement.

 

2. Resale
Registration.

 

 (a) On
or prior to the Filing Date, the Company shall prepare and file with the Commission a “resale” Registration Statement
providing for the resale of all Registrable Securities by means of an offering to be made on a continuous basis pursuant to Rule
415. The Registration Statement shall be on Form S-1 (or another appropriate form in accordance herewith). The Company shall (i)
not permit any securities other than the Registrable Securities to be included in the Registration Statement and (ii) use its
commercially reasonable efforts to cause the Registration Statement to be declared effective under the Securities Act as promptly
as possible after the filing thereof, but in any event prior to the Effectiveness Date, and to keep such Registration Statement
continuously effective under the Securities Act until such date as is the earlier of (x) the date when all Registrable Securities
covered by such Registration Statement have been sold or (y) the date on which the Registrable Securities may be sold without
any restriction pursuant to Rule 144 as determined by the counsel to the Company pursuant to a written opinion letter, addressed
to the Company’s transfer agent to such effect (the “Effectiveness Period”). The Company shall request
that the effective time of the Registration Statement be 4:00 p.m. Eastern Time on the Effectiveness Date. If at any time and
for any reason, an additional Registration Statement is required to be filed because at such time the actual number of Registrable
Securities exceeds the number of Registrable Securities remaining under the Registration Statement and such Registrable Securities
are not saleable under Rule 144, without limitation, the Company shall have twenty (20) Business Days to file such additional
Registration Statement, and the Company shall use its commercially reasonable efforts to cause such additional Registration Statement
to be declared effective by the Commission as soon as possible, but in no event later than sixty (60) days after such filing.

 

    	 

    	 

    

 

(b) Notwithstanding
anything to the contrary set forth in this Section 2, in the event the Commission does not permit the Company to register all
of the Registrable Securities in the Registration Statement because of the Commission’s application of Rule 415, the number
of Registrable Securities to be registered on such Registration Statement will be reduced in the order of the Registrable Securities
represented by the total number of Diluted Shares owned by the Holders, applied on a pro rata basis, The Company shall use its
commercially reasonable efforts to file additional Registration Statements to register the Registrable Securities that were not
registered in the initial Registration Statement and are not saleable under Rule 144 without limitation as promptly as possible
but in no event later than on the Filing Date and in a manner permitted by the Commission. For purposes of this Section 2(b),
“Filing Date” means with respect to each subsequent Registration Statement filed pursuant hereto, the later
of (i) sixty (60) days following the sale of substantially all of the Registrable Securities included in the initial Registration
Statement or any subsequent Registration Statement and (ii) six (6) months following the effective date of the initial Registration
Statement or any subsequent Registration Statement, as applicable, or such earlier date as permitted by the Commission. For purposes
of this Section 2(b), “Effectiveness Date” means with respect to each subsequent Registration Statement filed
pursuant hereto, the earlier of (A) the ninetieth (90th) day following the filing date of such Registration Statement
(or in the event such Registration Statement receives a “full review” by the Commission, the one hundred twentieth
(120th) day following such filing date) or (B) the date which is within three (3) Business Days after the date on which
the Commission informs the Company (i) that the Commission will not review such Registration Statement or (ii) that the
Company may request the acceleration of the effectiveness of such Registration Statement; provided that, if the
Effectiveness Date falls on a Saturday, Sunday or any other day which shall be a legal holiday or a day on which the Commission
is authorized or required by law or other government actions to close, the Effectiveness Date shall be the following Business
Day.

 

 (c) Each
Holder agrees to furnish to the Company a completed Selling Stockholder Questionnaire not more than ten (10) Business Days following
the date of this Agreement. Each Holder further agrees that it shall not be entitled to be named as a selling security holder
in the Registration Statement or use the Prospectus for offers and resales of Registrable Securities at any time, unless such
Holder has returned to the Company a completed and signed Selling Stockholder Questionnaire. If a Holder of Registrable Securities
returns a Selling Stockholder Questionnaire after the deadline specified in the previous sentence, the Company shall use its commercially
reasonable efforts to take such actions as are required to name such Holder as a selling security holder in the Registration Statement
or any pre-effective or post-effective amendment thereto and to include (to the extent not theretofore included) in the Registration
Statement the Registrable Securities identified in such late Selling Stockholder Questionnaire; provided that the Company
shall not be required to file an additional Registration Statement solely for such shares. Each Holder acknowledges and agrees
that the information in the Selling Stockholder Questionnaire will be used by the Company in the preparation of the Registration
Statement and hereby consents to the inclusion of such information in the Registration Statement. 

 

    	 

    	 

    

 

3. Registration
Procedures.

 

In
connection with the Company’s registration obligations hereunder, the Company shall:

 

 (a)
 Prepare and file with the Commission, on or prior to the Filing Date, a Registration Statement on Form S-1 (or another appropriate
form in accordance herewith) in accordance with the plan of distribution as set forth on Exhibit A hereto and in accordance
with applicable law, and cause the Registration Statement to become effective and remain effective as provided herein; provided,
however, that not less than five (5) Business Days prior to the filing of the Registration Statement or any related Prospectus
or any amendment or supplement thereto, the Company shall (i) furnish to the Holders copies of all such documents proposed to
be filed, which documents will be subject to the review of such Holders, and (ii) cause its officers and directors, counsel and
independent certified public accountants to respond to such inquiries as shall be necessary to conduct a reasonable review of
such documents. The Company shall not file the Registration Statement or any such Prospectus or any amendments or supplements
thereto to which the Purchasers shall reasonably object in writing within three (3) Business Days of their receipt thereof.

 

(b) (i)
Prepare and file with the Commission such amendments, including post-effective amendments, to the Registration Statement as may
be necessary to keep the Registration Statement continuously effective as to the applicable Registrable Securities for the Effectiveness
Period and prepare and file with the Commission such additional Registration Statements as necessary in order to register for
resale under the Securities Act all of the Registrable Securities; (ii) cause the related Prospectus to be amended or supplemented
by any required Prospectus supplement, and as so supplemented or amended to be filed pursuant to Rule 424 (or any similar provisions
then in force) promulgated under the Securities Act; (iii) respond as promptly as possible, but in no event later than fifteen
(15) Business Days (unless extended pursuant to an extension request submitted to the Commission), to any comments received from
the Commission with respect to the Registration Statement or any amendment thereto and as promptly as possible provide the Holders
true and complete copies of all correspondence from and to the Commission relating to the Registration Statement; (iv) file the
final prospectus pursuant to Rule 424 of the Securities Act no later than two (2) Business Days following the date the Registration
Statement is declared effective by the Commission; and (v) comply in all material respects with the provisions of the Securities
Act and the Exchange Act with respect to the disposition of all Registrable Securities covered by the Registration Statement during
the Effectiveness Period in accordance with the intended methods of disposition by the Holders thereof set forth in the Registration
Statement as so amended or in such Prospectus as so supplemented.

 

    	 

    	 

    

 

(c) Notify
the Holders of Registrable Securities as promptly as possible (and, in the case of (i)(A) below, not less than three (3) Business
Days prior to such filing, and in the case of (iii) below, on the same day of receipt by the Company of such notice from the Commission)
and (if requested by any such Person) confirm such notice in writing no later than one (1) Business Day following the day: (i)(A)
when a Prospectus or any Prospectus supplement or post-effective amendment to the Registration Statement is filed; (B) when the
Commission notifies the Company whether there will be a “review” of such Registration Statement and whenever the Commission
comments in writing on such Registration Statement and (C) with respect to the Registration Statement or any post-effective amendment,
when the same has become effective; (ii) of any request by the Commission or any other Federal or state governmental authority
for amendments or supplements to the Registration Statement or Prospectus or for additional information; (iii) of the issuance
by the Commission of any stop order suspending the effectiveness of the Registration Statement covering any or all of the Registrable
Securities or the initiation or threatening of any Proceedings for that purpose; (iv) of the receipt by the Company of any notification
with respect to the suspension of the qualification or exemption from qualification of any of the Registrable Securities for sale
in any jurisdiction, or the initiation or threatening of any Proceeding for such purpose; and (v) of the occurrence of any event
that makes any statement made in the Registration Statement or Prospectus or any document incorporated or deemed to be incorporated
therein by reference untrue in any material respect or that requires any revisions to the Registration Statement, Prospectus or
other documents so that, in the case of the Registration Statement or the Prospectus, as the case may be, it will not contain
any untrue statement of a material fact or omit to state any material fact required to be stated therein or necessary to make
the statements therein (in the case of the Prospectus, in the light of the circumstances under which they were made) not misleading.

 

 (d) Use
its commercially reasonable efforts to avoid the issuance of, or, if issued, obtain the withdrawal of, as promptly as possible,
(i) any order suspending the effectiveness of the Registration Statement or (ii) any suspension of the qualification (or exemption
from qualification) of any of the Registrable Securities for sale in any jurisdiction.

 

(e) If
requested by the Holders of a majority in interest of the Registrable Securities, (i) promptly incorporate in a Prospectus supplement
or post-effective amendment to the Registration Statement such information as the Company reasonably agrees should be included
therein and (ii) make all required filings of such Prospectus supplement or such post-effective amendment as soon as practicable
after the Company has received notification of the matters to be incorporated in such Prospectus supplement or post-effective
amendment.

 

(f) If
requested by any Holder, furnish to such Holder, without charge, at least one conformed copy of each Registration Statement and
each amendment thereto, including financial statements and schedules, all documents incorporated or deemed to be incorporated
therein by reference, and all exhibits to the extent requested by such Person (including those previously furnished or incorporated
by reference) promptly after the filing of such documents with the Commission.

 

    	 

    	 

    

 

(g) Promptly
deliver to each Holder, without charge, as many copies of the Prospectus or Prospectuses (including each form of prospectus) and
each amendment or supplement thereto as such Persons may reasonably request; and subject to the provisions of Sections 3(m) and
3(n), the Company hereby consents to the use of such Prospectus and each amendment or supplement thereto by each of the selling
Holders in connection with the offering and sale of the Registrable Securities covered by such Prospectus and any amendment or
supplement thereto.

 

(h) Prior
to any resale of Registrable Securities, use its commercially reasonable efforts to register or qualify or cooperate with the
selling Holders in connection with the registration or qualification (or exemption from such registration or qualification) of
such Registrable Securities for offer and sale under the securities or Blue Sky laws of such jurisdictions within the United States
as any Holder requests in writing, to keep each such registration or qualification (or exemption therefrom) effective during the
Effectiveness Period and to do any and all other acts or things necessary or advisable to enable the disposition in such jurisdictions
of the Registrable Securities covered by a Registration Statement; provided, however, that the Company shall not
be required to qualify generally to do business in any jurisdiction where it is not then so qualified or to take any action that
would subject it to general service of process in any such jurisdiction where it is not then so subject or subject the Company
to any material tax in any such jurisdiction where it is not then so subject.

 

 (i) Cooperate
with the Holders to facilitate the timely preparation and delivery of certificates representing Registrable Securities to be sold
pursuant to a Registration Statement, which certificates, to the extent permitted by the Purchase Agreement and applicable federal
and state securities laws, shall be free of all restrictive legends, and to enable such Registrable Securities to be in such denominations
and registered in such names as any Holder may request in connection with any sale of Registrable Securities.

 

(j) Upon
the occurrence of any event contemplated by Section 3(c)(vi), as promptly as possible, prepare a supplement or amendment, including
a post-effective amendment, to the Registration Statement or a supplement to the related Prospectus or any document incorporated
or deemed to be incorporated therein by reference, and file any other required document so that, as thereafter delivered, neither
the Registration Statement nor such Prospectus will contain an untrue statement of a material fact or omit to state a material
fact required to be stated therein or necessary to make the statements therein (in the case of the Prospectus, in the light of
the circumstances under which they were made) not misleading.

 

(k) Use
its commercially reasonable efforts to cause all Registrable Securities relating to the Registration Statement, to be quoted or
listed on a securities exchange, quotation system or market, if any, on which similar securities issued by the Company are then
listed or traded as and when required pursuant to the Purchase Agreement.

 

(l) Comply
in all material respects with all applicable rules and regulations of the Commission and make generally available to its security
holders all documents filed or required to be filed with the Commission, including, but not limited, to, earning statements satisfying
the provisions of Section 11(a) of the Securities Act and Rule 158 not later than 45 days after the end of any 12-month period
(or 90 days after the end of any 12-month period if such period is a fiscal year) commencing on the first day of the first fiscal
quarter of the Company after the effective date of the Registration Statement, which statement shall conform to the requirements
of Rule 158.

 

    	 

    	 

    

 

(m) The
Company may require each selling Holder to furnish to the Company a certified statement as to the number of shares of Common Stock
beneficially owned by such Holder and the natural persons thereof that have voting and dispositive control over the Registrable
Securities. During any periods that the Company is unable to meet its obligations hereunder with respect to the registration of
the Registrable Securities solely because any Holder fails to furnish such information within five (5) Business Days of the Company’s
request, any liquidated damages that are accruing at such time as to such Holder only shall be tolled and any Event that may otherwise
occur solely because of such delay shall be suspended as to such Holder only, until such information is delivered to the Company.

 

If
the Registration Statement refers to any Holder by name or otherwise as the holder of any securities of the Company, then such
Holder shall have the right to require (if such reference to such Holder by name or otherwise is not required by the Securities
Act or any similar federal statute then in force) the deletion of the reference to such Holder in any amendment or supplement
to the Registration Statement filed or prepared subsequent to the time that such reference ceases to be required.

 

Each
Holder covenants and agrees that it will not sell any Registrable Securities under the Registration Statement until the Company
has electronically filed the Prospectus as then amended or supplemented as contemplated in Section 3(g) and notice from the Company
that the Registration Statement and any post-effective amendments thereto have become effective as contemplated by Section 3(c).

 

Each
Holder agrees by its acquisition of such Registrable Securities that, upon receipt of a notice from the Company of the occurrence
of any event of the kind described in Section 3(c)(ii), 3(c)(iii), 3(c)(iv), 3(c)(v), 3(c)(vi) or 3(n), such Holder will forthwith
discontinue disposition of such Registrable Securities under the Registration Statement until such Holder’s receipt of the
copies of the supplemented Prospectus and/or amended Registration Statement contemplated by Section 3(j), or until it is advised
in writing (the “Advice”) by the Company that the use of the applicable Prospectus may be resumed, and, in
either case, has received copies of any additional or supplemental filings that are incorporated or deemed to be incorporated
by reference in such Prospectus or Registration Statement.

 

(n) If
(i) there is material non-public information regarding the Company which the Company’s Board of Directors (the “Board”)
determines not to be in the Company’s best interest to disclose and which the Company is not otherwise required to disclose,
(ii) there is a significant business opportunity (including, but not limited to, the acquisition or disposition of assets (other
than in the ordinary course of business) or any merger, consolidation, tender offer or other similar transaction) available to
the Company which the Board determines not to be in the Company’s best interest to disclose, or (iii) the Company is required
to file a post-effective amendment to the Registration Statement to incorporate the Company’s quarterly and annual reports
and audited financial statements on Forms 10-Q and 10-K, then the Company may (x) postpone or suspend filing of a registration
statement for a period not to exceed forty-five (45) consecutive days or (y) postpone or suspend effectiveness of a registration
statement for a period not to exceed forty-five (45) consecutive days; provided that the Company may not postpone or suspend
effectiveness of a registration statement under this Section 3(n) for more than ninety (90) days in the aggregate during any three
hundred sixty (360) day period; provided, however, that no such postponement or suspension shall be permitted for
consecutive twenty (20) day periods arising out of the same set of facts, circumstances or transactions.

 

    	 

    	 

    

 

4. Registration
Expenses.

 

All
fees and expenses incident to the performance of or compliance with this Agreement by the Company, except as and to the extent
specified in this Section 4, shall be borne by the Company whether or not the Registration Statement is filed or becomes effective
and whether or not any Registrable Securities are sold pursuant to the Registration Statement. The fees and expenses referred
to in the foregoing sentence shall include, without limitation, (i) all registration and filing fees (including, without limitation,
fees and expenses (A) with respect to filings required to be made with any securities exchange or market on which Registrable
Securities are required hereunder to be listed, if any, (B) with respect to filing fees required to be paid to the Financial Industry
Regulatory Authority, Inc. (including, without limitation, pursuant to FINRA Rule 5110) and (C) in compliance with state securities
or Blue Sky laws (including, without limitation, fees and disbursements of one counsel for the Holders up to a maximum amount
of $5,000 in connection with Blue Sky qualifications of the Registrable Securities and determination of the eligibility of the
Registrable Securities for investment under the laws of such jurisdictions as the Holders of a majority of Registrable Securities
may designate)), (ii) printing expenses (including, without limitation, expenses of printing certificates for Registrable Securities
and of printing prospectuses if the printing of prospectuses is requested by the holders of a majority of the Registrable Securities
included in the Registration Statement), (iii) messenger, telephone and delivery expenses, (iv) Securities Act liability insurance,
if the Company so desires such insurance, and (v) fees and expenses of all other Persons retained by the Company in connection
with the consummation of the transactions contemplated by this Agreement, including, without limitation, the Company’s independent
public accountants (including the expenses of any comfort letters or costs associated with the delivery by independent public
accountants of a comfort letter or comfort letters). In addition, the Company shall be responsible for all of its internal expenses
incurred in connection with the consummation of the transactions contemplated by this Agreement (including, without limitation,
all salaries and expenses of its officers and employees performing legal or accounting duties), the expense of any annual audit,
the fees and expenses incurred in connection with the listing of the Registrable Securities on any securities exchange if required
hereunder. The Company shall not be responsible for any discounts, commissions, transfer taxes or other similar fees incurred
by the Holders in connection with the sale of the Registrable Securities.

 

    	 

    	 

    

 

5.  Indemnification.

 

(a) Indemnification
by the Company. The Company shall, notwithstanding any termination of this Agreement, indemnify and hold harmless each Holder,
the officers, directors, managers, partners, members, shareholders, agents, brokers, investment advisors and employees of each
of them, each Person who controls any such Holder (within the meaning of Section 15 of the Securities Act or Section 20 of the
Exchange Act) and the officers, directors, agents and employees of each such controlling Person, to the fullest extent permitted
by applicable law, from and against any and all losses, claims, damages, liabilities, costs (including, without limitation, costs
of preparation and attorneys’ fees) and expenses (collectively, “Losses”), as incurred, arising out of
or relating to any violation of securities laws or untrue statement of a material fact contained in the Registration Statement,
any Prospectus or any form of prospectus or in any amendment or supplement thereto or in any preliminary prospectus, or arising
out of or relating to any omission of a material fact required to be stated therein or necessary to make the statements therein
(in the case of any Prospectus or form of prospectus or supplement thereto, in the light of the circumstances under which they
were made) not misleading, except to the extent, but only to the extent, that such untrue statements or omissions are based solely
upon information regarding such Holder or such other Indemnified Party furnished in writing to the Company by such Holder for
use therein. The Company shall notify the Holders promptly of the institution, threat or assertion of any Proceeding of which
the Company is aware in connection with the transactions contemplated by this Agreement.

 

(b) Indemnification
by Holders. Each Holder shall, severally and not jointly, indemnify and hold harmless the Company, its directors, officers,
agents and employees, each Person who controls the Company (within the meaning of Section 15 of the Securities Act and Section
20 of the Exchange Act), and the directors, officers, agents and employees of such controlling Persons, to the fullest extent
permitted by applicable law, from and against all Losses, as incurred, arising out of or based upon any untrue statement of a
material fact contained in the Registration Statement, any Prospectus, or any form of prospectus, or in any amendment or supplement
thereto, or arising out of or based upon any omission of a material fact required to be stated therein or necessary to make the
statements therein (in the case of any Prospectus or form of prospectus or supplement thereto, in the light of the circumstances
under which they were made) not misleading, to the extent, but only to the extent, that such untrue statement or omission is contained
in any information so furnished in writing by such Holder or other Indemnifying Party to the Company specifically for inclusion
in the Registration Statement or such Prospectus. Notwithstanding anything to the contrary contained herein, each Holder shall
be liable under this Section 5(b) only for the lesser of (a) the actual damages incurred or (b) that amount as does not exceed
the gross proceeds to such Holder as a result of the sale of his/her/its Registrable Securities pursuant to such Registration
Statement.

 

 (c) Conduct
of Indemnification Proceedings. If any Proceeding shall be brought or asserted against any Person entitled to indemnity hereunder
(an “Indemnified Party”), such Indemnified Party promptly shall promptly notify the Person from whom indemnity
is sought (the “Indemnifying Party”) in writing, and the Indemnifying Party shall be entitled to assume the
defense thereof, including the employment of counsel reasonably satisfactory to the Indemnified Party and the payment of all fees
and expenses incurred in connection with defense thereof; provided that the failure of any Indemnified Party to give such notice
shall not relieve the Indemnifying Party of its obligations or liabilities pursuant to this Agreement, except (and only) to the
extent that it shall be finally determined by a court of competent jurisdiction (which determination is not subject to appeal
or further review) that such failure shall have proximately and materially adversely prejudiced the Indemnifying Party.

 

    	 

    	 

    

 

An
Indemnified Party shall have the right to employ separate counsel in any such Proceeding and to participate in the defense thereof,
but the fees and expenses of such counsel shall be at the expense of such Indemnified Party or Parties unless: (1) the Indemnifying
Party has agreed in writing to pay such fees and expenses; or (2) the Indemnifying Party shall have failed promptly to assume
the defense of such Proceeding and to employ counsel reasonably satisfactory to such Indemnified Party in any such Proceeding;
or (3) the named parties to any such Proceeding (including any impleaded parties) include both such Indemnified Party and the
Indemnifying Party, and such parties shall have been advised by counsel that a conflict of interest is likely to exist if the
same counsel were to represent such Indemnified Party and the Indemnifying Party (in which case, if such Indemnified Party notifies
the Indemnifying Party in writing that it elects to employ separate counsel at the expense of the Indemnifying Party, the Indemnifying
Party shall not have the right to assume the defense thereof and such counsel shall be at the expense of the Indemnifying Party).
The Indemnifying Party shall not be liable for any settlement of any such Proceeding effected without its written consent, which
consent shall not be unreasonably withheld or delayed. No Indemnifying Party shall, without the prior written consent of the Indemnified
Party, effect any settlement of any pending or threatened Proceeding in respect of which any Indemnified Party is a party and
indemnity has been sought hereunder, unless such settlement includes an unconditional release of such Indemnified Party from all
liability on claims that are the subject matter of such Proceeding.

 

 (d) Contribution.
If a claim for indemnification under Section 5(a) or 5(b) is due but unavailable to an Indemnified Party because of a failure
or refusal of a governmental authority to enforce such indemnification in accordance with its terms (by reason of public policy
or otherwise), then each Indemnifying Party, in lieu of indemnifying such Indemnified Party, shall contribute to the amount paid
or payable by such Indemnified Party as a result of such Losses, in such proportion as is appropriate to reflect the relative
benefits received by the Indemnifying Party on the one hand and the Indemnified Party on the other from the offering of the Preferred
Stock and Warrants. If, but only if, the allocation provided by the foregoing sentence is not permitted by applicable law, the
allocation of contribution shall be made in such proportion as is appropriate to reflect not only the relative benefits referred
to in the foregoing sentence but also the relative fault, as applicable, of the Indemnifying Party and Indemnified Party in connection
with the actions, statements or omissions that resulted in such Losses as well as any other relevant equitable considerations.
The relative fault of such Indemnifying Party and Indemnified Party shall be determined by reference to, among other things, whether
any action in question, including any untrue statement of a material fact or omission of a material fact, has been taken or made
by, or relates to information supplied by, such Indemnifying Party or Indemnified Party, and the parties’ relative
intent, knowledge, access to information and opportunity to correct or prevent such action, statement or omission. The amount
paid or payable by a party as a result of any Losses shall be deemed to include, subject to the limitations set forth in Section
5(c), any reasonable attorneys’ or other reasonable fees or expenses incurred by such party in connection with any Proceeding
to the extent such party would have been indemnified for such fees or expenses if the indemnification provided for in this Section
was available to such party in accordance with its terms. In no event shall any selling Holder be required to contribute an amount
under this Section 5(d) in excess of the gross proceeds received by such Holder upon sale of such Holder’s Registrable Securities
pursuant to the Registration Statement giving rise to such contribution obligation.

 

    	 

    	 

    

 

The
parties hereto agree that it would not be just and equitable if contribution pursuant to this Section 5(d) were determined by
pro rata allocation or by any other method of allocation that does not take into account the equitable considerations referred
to in the immediately preceding paragraph. No Person guilty of fraudulent misrepresentation (within the meaning of Section 11(f)
of the Securities Act) shall be entitled to contribution from any Person who was not guilty of such fraudulent misrepresentation.

 

The
indemnity and contribution agreements contained in this Section are in addition to any liability that the Indemnifying Parties
may have to the Indemnified Parties pursuant to applicable law.

 

6. Rule
144.

 

As
long as any Holder owns Notes, Warrants or Registrable Securities, the Company covenants to timely file (or obtain extensions
in respect thereof and file within the applicable grace period) all reports required to be filed by the Company after the date
hereof pursuant to Section 13(a) or 15(d) of the Exchange Act. As long as any Holder owns Notes, Warrants or Registrable Securities,
if the Company is not required to file reports pursuant to Section 13(a) or 15(d) of the Exchange Act, it will prepare and furnish
to the Holders and make publicly available in accordance with Rule 144(c) promulgated under the Securities Act, annual and quarterly
financial statements, together with a discussion and analysis of such financial statements in form and substance substantially
similar to those that would otherwise be required to be included in reports required by Section 13(a) or 15(d) of the Exchange
Act, as well as any other information required thereby, in the time period that such filings would have been required to have
been made under the Exchange Act. The Company further covenants that it will take such further action as any Holder may reasonably
request, all to the extent reasonably required from time to time to enable such Person to sell Warrant Shares without registration
under the Securities Act within the limitation of the exemptions provided by Rule 144 promulgated under the Securities Act, including
providing any legal opinions relating to such sale pursuant to Rule 144. Upon the request of any Holder, the Company shall deliver
to such Holder a written certification of a duly authorized officer as to whether it has complied with such requirements.

 

7. Miscellaneous.

 

(a) Remedies.
In the event of a breach by the Company or by a Holder of any of their obligations under this Agreement, such Holder or the Company,
as the case may be, in addition to being entitled to exercise all rights granted by law and under this Agreement, including recovery
of damages, will be entitled to specific performance of its rights under this Agreement. Each of the Company and each Holder
agrees that monetary damages would not provide adequate compensation for any losses incurred by reason of a breach by it
of any of the provisions of this Agreement and hereby further agrees that, in the event of any action for specific performance
in respect of such breach, it shall waive the defense that a remedy at law would be adequate.

 

(b) No
Inconsistent Agreements. The Company has not entered into, and shall not enter into on or after the date of this Agreement,
any agreement with respect to its securities that is inconsistent with the rights granted to the Holders in this Agreement or
otherwise conflicts with the provisions hereof. Other than the purchasers of the Converted Offering and the holders of the Promissory
Notes, the Company has not previously entered into any agreement that is currently in effect granting any registration rights
with respect to any of its securities to any Person. Without limiting the generality of the foregoing, without the written consent
of the Holders of a majority of the then outstanding Registrable Securities, the Company shall not grant to any Person the right
to request the Company to register any securities of the Company under the Securities Act unless the rights so granted are subject
in all respects to the prior rights in full of the Holders set forth herein, and are not otherwise in conflict with the provisions
of this Agreement.

 

    	 

    	 

    

 

(c) No
Piggyback on Registrations for Other Securities. Neither the Company nor any of its security holders may include securities
of the Company in the Registration Statement, and the Company shall not after the date hereof enter into any agreement providing
such right to any of its security holders, unless the right so granted is subject in all respects to the prior rights in full
of the Holders set forth herein, and is not otherwise in conflict with the provisions of this Agreement.

 

(d) Piggy-Back
Registrations for Registrable Securities. If at any time when there is not an effective Registration Statement covering the
Note Shares, Warrant Shares or Converted Offering Shares, the Company shall determine to prepare and file with the Commission
a registration statement relating to an offering for its own account or the account of others under the Securities Act of any
of its equity securities, other than on Form S-4 or Form S-8 (each as promulgated under the Securities Act) or their then equivalents
relating to equity securities to be issued solely in connection with any acquisition of any entity or business or equity securities
issuable in connection with stock option or other employee benefit plans, the Company shall send to each Holder of Registrable
Securities written notice of such determination and, if within ten (10) calendar days after receipt of such notice, or within
such shorter period of time as may be specified by the Company in such written notice as may be necessary for the Company to comply
with its obligations with respect to the timing of the filing of such registration statement, any such Holder shall so request
in writing (which request shall specify the Registrable Securities intended to be disposed of by the such Holder), the Company
will cause the registration under the Securities Act of all Registrable Securities which the Company has been so requested to
register by the Holder, to the extent requisite to permit the disposition of the Registrable Securities so to be registered, provided
that if at any time after giving written notice of its intention to register any securities and prior to the effective date of
the registration statement filed in connection with such registration, the Company shall determine for any reason not to register
or to delay registration of such securities, the Company may, at its election, give written notice of such determination to such
Holder and, thereupon, (i) in the case of a determination not to register, shall be relieved of its obligation to register any
Registrable Securities in connection with such registration (but not from its obligation to pay expenses in accordance with Section
4 hereof), and (ii) in the case of a determination to delay registering, shall be permitted to delay registering any Registrable
Securities being registered pursuant to this Section 7(d) for the same period as the delay in registering such other securities.
The Company shall include in such registration statement all or any part of such Registrable Securities such Holder requests to
be registered; provided, however, that the Company shall not be required to register any Registrable Securities
pursuant to this Section 7(d) that are eligible for sale pursuant to Rule 144 of the Securities Act. In the case of an underwritten
public offering, if the managing underwriter(s) or underwriter(s) should reasonably object to the inclusion of the Registrable
Securities in such registration statement, then if the Company after consultation with the managing underwriter should reasonably
determine that the inclusion of such Registrable Securities would materially adversely affect the offering contemplated in such
registration statement, and based on such determination recommends inclusion in such registration statement of fewer or none of
the Registrable Securities of the Holders, then (x) the number of Registrable Securities of the Holders included in such registration
statement shall be reduced among such Holders based upon the number of Registrable Securities requested to be included
in the registration in the order set forth in Section 2(b) hereof, if the Company after consultation with the underwriter(s) recommends
the inclusion of fewer Registrable Securities, or (y) none of the Registrable Securities of the Holders shall be included in such
registration statement, if the Company after consultation with the underwriter(s) recommends the inclusion of none of such Registrable
Securities; provided, however, that if securities are being offered for the account of other persons or entities
as well as the Company, such reduction shall not represent a greater fraction of the number of Registrable Securities intended
to be offered by the Holders than the fraction of similar reductions imposed on such other persons or entities (other than the
Company). For purposes of this Section 7(d), Registrable Securities shall include any shares actually issued to the Purchasers
pursuant to the Securities Escrow Agreement.

 

    	 

    	 

    

 

(e) Subordinated
Registration Rights. Notwithstanding any other provision set forth herein, the Purchasers acknowledge and agree that the registration
rights so granted to the Purchasers in this Agreement are subject in all respects to the full realization of the registration
rights granted to the purchasers of the Converted Offering and to the holders of the Promissory Notes.

 

(f) Intentionally
Left Blank.

 

(g) Amendments
and Waivers. The provisions of this Agreement, including the provisions of this sentence, may not be amended, modified or
supplemented, and waivers or consents to departures from the provisions hereof may not be given, unless the same shall be in writing
and signed by the Company and the Holders of a majority of the then outstanding Registrable Securities.

 

(h) Notices.
All notices and other communications given or made pursuant to this Agreement will be in writing and will be deemed effectively
given: (i) upon personal delivery to the party to be notified; (ii) when sent by confirmed electronic mail or facsimile, if sent
during normal business hours of the recipient, and if not so confirmed, then on the next business day; (iii) five days after having
been sent by registered or certified mail, return receipt requested, postage prepaid; or (iv) one day after deposit with a nationally
recognized overnight courier, specifying next day delivery, with written verification of receipt. All communications will be sent
to: (x) the Company at the address set forth in the introductory paragraph of this Agreement, Attention: Chief Executive Officer
or facsimile number 310-301-7748]; and (y) the Purchasers at the addresses set forth on the signature page of this Agreement,
(or at such other addresses as will be specified by notice given in accordance with this Section 5.4). The addresses for
such communications shall be:

 

    	 

    	 

    

 

	If
    to the Company:	eWellness
                                         Healthcare Corporation

        11825
        Major Street

        Culver
        City, California 90230

	 	 
	with
    copies to

 (which shall not constitute notice):	Hunter
                                         Taubman Weiss, LLP

        130
        W. 4nd Street, Suite 1050

        New
        York, New York 10036

        Attn:
        Rachael Schmierer, Esq.

        Tel:
        917-512-0828

        Fax:
        212-202-6380

	 	 
	If
    to any Purchaser:	At
    the address of such Purchaser set forth on Schedule I to this Agreement

 

Any
party hereto may from time to time change its address for notices by giving at least ten (10) days written notice of such changed
address to the other party hereto.

 

(i) Successors
and Assigns. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and permitted
assigns and shall inure to the benefit of each Holder and its successors and assigns. The Company may not assign this Agreement
or any of its rights or obligations hereunder without the prior written consent of each Holder. Each Purchaser may assign its
rights hereunder in the manner and to the Persons as permitted under the Purchase Agreement.

 

(j) Assignment
of Registration Rights. The rights of each Holder hereunder, including the right to have the Company register for resale Registrable
Securities in accordance with the terms of this Agreement, shall be automatically assignable by each Holder to any Person who
acquires all or a portion of the Note, the Warrants or the Registrable Securities if: (i) the Holder agrees in writing
with the transferee or assignee to assign such rights, and a copy of such agreement is furnished to the Company within a reasonable
time after such assignment, (ii) the Company is, within a reasonable time after such transfer or assignment, furnished with written
notice of (a) the name and address of such transferee or assignee, and (b) the securities with respect to which such registration
rights are being transferred or assigned, (iii) following such transfer or assignment the further disposition of such securities
by the transferee or assignees is restricted under the Securities Act and applicable state securities laws unless such securities
are registered in a Registration Statement under this Agreement (in which case the Company shall be obligated to amend such Registration
Statement to reflect such transfer or assignment) or are otherwise exempt from registration, (iv) at or before the time the Company
receives the written notice contemplated by clause (ii) of this Section, the transferee or assignee agrees in writing with the
Company to be bound by all of the provisions of this Agreement, and (v) such transfer shall have been made in accordance with
the applicable requirements of the Purchase Agreement. The rights to assignment shall apply to the Holders (and to subsequent)
successors and assigns.

 

    	 

    	 

    

 

(k) Counterparts.
This Agreement may be executed in any number of counterparts, each of which when so executed shall be deemed to be an original
and, all of which taken together shall constitute one and the same Agreement and shall become effective when counterparts have
been signed by each party and delivered to the other parties hereto, it being understood that all parties need not sign the same
counterpart. In the event that any signature is delivered by facsimile transmission, such signature shall create a valid binding
obligation of the party executing (or on whose behalf such signature is executed) the same with the same force and effect as if
such facsimile signature were the original thereof.

 

(l) Governing
Law; Jurisdiction. This Agreement shall be governed by and construed in accordance with the internal laws of the State of
Nevada, without giving effect to any of the conflicts of law principles which would result in the application of the substantive
law of another jurisdiction. This Agreement shall not be interpreted or construed with any presumption against the party causing
this Agreement to be drafted. The Company and the Holders agree that venue for any dispute arising under this Agreement will lie
exclusively in the state or federal courts located in Clark County, Nevada, and the parties irrevocably waive any right to raise
forum non conveniens or any other argument that Nevada is not the proper venue. The Company and the Holders irrevocably
consent to personal jurisdiction in the state and federal courts of the state of Nevada. The Company and the Holders consent to
process being served in any such suit, action or proceeding by mailing a copy thereof to such party at the address in effect for
notices to it under this Agreement and agrees that such service shall constitute good and sufficient service of process and notice
thereof. Nothing in this Section 7(k) shall affect or limit any right to serve process in any other manner permitted by law. The
Company and the Holders hereby agree that the prevailing party in any suit, action or proceeding arising out of or relating to
this Agreement or the Purchase Agreement, shall be entitled to reimbursement for reasonable legal fees from the non-prevailing
party. The parties hereby waive all rights to a trial by jury.

 

(m) Cumulative
Remedies. The remedies provided herein are cumulative and not exclusive of any remedies provided by law.

 

(n) Severability.
If any term, provision, covenant or restriction of this Agreement is held to be invalid, illegal, void or unenforceable in any
respect, the remainder of the terms, provisions, covenants and restrictions set forth herein shall remain in full force and effect
and shall in no way be affected, impaired or invalidated, and the parties hereto shall use their reasonable efforts to find and
employ an alternative means to achieve the same or substantially the same result as that contemplated by such term, provision,
covenant or restriction. It is hereby stipulated and declared to be the intention of the parties that they would have executed
the remaining terms, provisions, covenants and restrictions without including any of such that may be hereafter declared invalid,
illegal, void or unenforceable.

 

(o) Headings.
The headings herein are for convenience only, do not constitute a part of this Agreement and shall not be deemed to limit or affect
any of the provisions hereof.

 

(p) Shares
Held by the Company and its Affiliates. Whenever the consent or approval of Holders of a specified percentage of Registrable
Securities is required hereunder, Registrable Securities held by the Company or its Affiliates (other than any Holder or transferees
or successors or assigns thereof if such Holder is deemed to be an Affiliate solely by reason of its holdings of such Registrable
Securities) shall not be counted in determining whether such consent or approval was given by the Holders of such required percentage.

 

    	 

    	 

    

 

(q) Independent
Nature of Purchasers. The Company acknowledges that the obligations of each Purchaser under the Transaction Documents are
several and not joint with the obligations of any other Purchaser, and no Purchaser shall be responsible in any way for the performance
of the obligations of any other Purchaser under the Transaction Documents. The Company acknowledges that the decision of each
Purchaser to purchase Securities pursuant to the Purchase Agreement has been made by such Purchaser independently of any other
Purchaser and independently of any information, materials, statements or opinions as to the business, affairs, operations, assets,
properties, liabilities, results of operations, condition (financial or otherwise) or prospects of the Company or of its Subsidiaries
which may have been made or given by any other Purchaser or by any agent or employee of any other Purchaser, and no Purchaser
or any of its agents or employees shall have any liability to any Purchaser (or any other person) relating to or arising from
any such information, materials, statements or opinions. The Company acknowledges that nothing contained herein, or in any Transaction
Document, and no action taken by any Purchaser pursuant hereto or thereto (including, but not limited to, the (i) inclusion of
a Purchaser in the Registration Statement and (ii) review by, and consent to, such Registration Statement by a Purchaser) shall
be deemed to constitute the Purchasers as a partnership, an association, a joint venture or any other kind of entity, or create
a presumption that the Purchasers are in any way acting in concert or as a group with respect to such obligations or the transactions
contemplated by the Transaction Documents. The Company acknowledges that each Purchaser shall be entitled to independently protect
and enforce its rights, including without limitation, the rights arising out of this Agreement or out of the other Transaction
Documents, and it shall not be necessary for any other Purchaser to be joined as an additional party in any proceeding for such
purpose. The Company acknowledges that it has elected to provide all Purchasers with the same terms and Transaction Documents
for the convenience of the Company and not because it was required or requested to do so by the Purchasers. The Company acknowledges
that such procedure with respect to the Transaction Documents in no way creates a presumption that the Purchasers are in any way
acting in concert or as a group with respect to the Transaction Documents or the transactions contemplated hereby or thereby.

 

[REMAINDER
OF PAGE INTENTIONALLY LEFT BLANK]

 

    	 

    	 

    

 

 IN
WITNESS WHEREOF, the parties hereto have caused this Registration Rights Agreement to be duly executed by their respective authorized
persons as of the date first indicated above.

 

	 	eWellness Healthcare Corporation
	 	 	 
	 	By:	 
	 	Name:
    	Darwin
    Fogt
	 	Title:	Chief
    Executive Officer
	 	 	 
	 	PURCHASERS: 
	 	 	 
	 	By:	 
	 	Name:	 
	 	Title:
    	 

 

[Signature
Page to Registration Rights Agreement]

 

    	 

    	 

    

 

Schedule
I

Purchasers

 

	Purchaser	Address
	 	 
	 	 
	 	 
	 	 
	 	 
	 	 
	 	 
	 	 
	 	 
	 	 
	 	 
	 	 
	 	 
	 	 
	 	 
	 	 
	 	 
	 	 

 

    	 

    	 

    

 

Exhibit
A

 

Plan
of Distribution

 

The
selling security holders and any of their pledgees, donees, assignees and successors-in-interest may, from time to time, sell
any or all of their shares of common stock being offered under this prospectus on any stock exchange, market or trading facility
on which shares of our common stock are traded or in private transactions. These sales may be at fixed or negotiated prices. The
selling security holders may use any one or more of the following methods when disposing of shares:

 

	 	●	ordinary
    brokerage transactions and transactions in which the broker-dealer solicits purchasers;
	 	 	 
	 	●	block
    trades in which the broker-dealer will attempt to sell the shares as agent but may position and resell a portion of the block
    as principal to facilitate the transaction;
	 	 	 
	 	●	purchases
    by a broker-dealer as principal and resales by the broker-dealer for its account;
	 	 	 
	 	●	an
    exchange distribution in accordance with the rules of the applicable exchange;
	 	 	 
	 	●	privately
    negotiated transactions;
	 	 	 
	 	●	to
    cover short sales made after the date that the registration statement of which this prospectus is a part is declared effective
    by the Commission;
	 	 	 
	 	●	broker-dealers
    may agree with the selling security holders to sell a specified number of such shares at a stipulated price per share;
	 	 	 
	 	●	a
    combination of any of these methods of sale; and
	 	 	 
	 	●	any
    other method permitted pursuant to applicable law.

 

The
shares may also be sold under Rule 144 under the Securities Act of 1933, as amended (“Securities Act”), if available,
rather than under this prospectus. The selling security holders have the sole and absolute discretion not to accept any purchase
offer or make any sale of shares if they deem the purchase price to be unsatisfactory at any particular time.

 

The
selling security holders may pledge their shares to their brokers under the margin provisions of customer agreements. If a selling
security holder defaults on a margin loan, the broker may, from time to time, offer and sell the pledged shares.

 

Broker-dealers
engaged by the selling security holders may arrange for other broker-dealers to participate in sales. Broker-dealers may receive
commissions or discounts from the selling security holders (or, if any broker-dealer acts as agent for the purchaser of shares,
from the purchaser) in amounts to be negotiated, which commissions as to a particular broker or dealer may be in excess of customary
commissions to the extent permitted by applicable law.

 

    	 

    	 

    

 

If
sales of shares offered under this prospectus are made to broker-dealers as principals, we would be required to file a post-effective
amendment to the registration statement of which this prospectus is a part. In the post-effective amendment, we would be required
to disclose the names of any participating broker-dealers and the compensation arrangements relating to such sales.

 

The
selling security holders and any broker-dealers or agents that are involved in selling the shares offered under this prospectus
may be deemed to be “underwriters” within the meaning of the Securities Act in connection with these sales. Commissions
received by these broker-dealers or agents and any profit on the resale of the shares purchased by them may be deemed to be underwriting
commissions or discounts under the Securities Act. Any broker-dealers or agents that are deemed to be underwriters may not sell
shares offered under this prospectus unless and until we set forth the names of the underwriters and the material details of their
underwriting arrangements in a supplement to this prospectus or, if required, in a replacement prospectus included in a post-effective
amendment to the registration statement of which this prospectus is a part.

 

The
selling security holders and any other persons participating in the sale or distribution of the shares offered under this prospectus
will be subject to applicable provisions of the Exchange Act, and the rules and regulations under that act, including Regulation
M. These provisions may restrict activities of, and limit the timing of purchases and sales of any of the shares by, the selling
security holders or any other person. Furthermore, under Regulation M, persons engaged in a distribution of securities are prohibited
from simultaneously engaging in market making and other activities with respect to those securities for a specified period of
time prior to the commencement of such distributions, subject to specified exceptions or exemptions. All of these limitations
may affect the marketability of the shares.

 

If
any of the shares of common stock offered for sale pursuant to this prospectus are transferred other than pursuant to a sale under
this prospectus, then subsequent holders could not use this prospectus until a post-effective amendment or prospectus supplement
is filed, naming such holders. We offer no assurance as to whether any of the selling security holders will sell all or any portion
of the shares offered under this prospectus.

 

We
have agreed to pay all fees and expenses we incur incident to the registration of the shares being offered under this prospectus.
However, each selling security holder and purchaser is responsible for paying any discounts, commissions and similar selling expenses
they incur.

 

We
and the selling security holders have agreed to indemnify one another against certain losses, damages and liabilities arising
in connection with this prospectus, including liabilities under the Securities Act.

 

    	 

    	 

    

 

Exhibit
B

 

Selling
Stockholder Notice and Questionnaire

 

The
undersigned understands that eWellness Healthcare Corporation (the “Company”) intends to file with the Securities
and Exchange Commission a registration statement on Form S-1 (the “Resale Registration Statement”) for the
registration and the resale under Rule 415 of the Securities Act of 1933, as amended (the “Securities Act”),
of the Registrable Securities in accordance with the terms of the Registration Rights Agreement entered into by the Company and
the undersigned (the “Agreement”). All capitalized terms not otherwise defined herein shall have the meanings
ascribed thereto in the Agreement.

 

In
order to sell or otherwise dispose of any Registrable Securities pursuant to the Resale Registration Statement, a holder of Registrable
Securities generally will be required to be named as a selling stockholder in the related prospectus or a supplement thereto (as
so supplemented, the “Prospectus”), deliver the Prospectus to purchasers of Registrable Securities (including
pursuant to Rule 172 under the Securities Act) and be bound by the provisions of the Agreement (including certain indemnification
provisions, as described below). Holders must complete and deliver this Notice and Questionnaire in order to be named as selling
stockholders in the Prospectus. Holders of Registrable Securities who do not complete, execute and return this Notice and Questionnaire
within ten (10) Business Days following the date of the Agreement (1) will not be named as selling stockholders in the Resale
Registration Statement or the Prospectus and (2) may not use the Prospectus for resales of Registrable Securities.

 

Certain
legal consequences arise from being named as a selling stockholder in the Resale Registration Statement and the Prospectus. Holders
of Registrable Securities are advised to consult their own securities law counsel regarding the consequences of being named or
not named as a selling stockholder in the Resale Registration Statement and the Prospectus.

 

NOTICE

 

The
undersigned holder (the “Selling Stockholder”) of Registrable Securities hereby gives notice to the Company
of its intention to sell or otherwise dispose of Registrable Securities owned by it and listed below in Item (3), unless otherwise
specified in Item (3), pursuant to the Resale Registration Statement. The undersigned, by signing and returning this Notice and
Questionnaire, understands and agrees that it will be bound by the terms and conditions of this Notice and Questionnaire and the
Agreement.

 

The
undersigned hereby provides the following information to the Company and represents and warrants that such information is accurate
and complete:

 

    	 

    	 

    

 

QUESTIONNAIRE

 

	1.	Name.

 

	 	(a)	Full
    Legal Name of Selling Stockholder:

 

	 	 

 

	 	(b)	Full
    Legal Name of Registered Holder (if not the same as (a) above) through which Registrable Securities Listed in Item 3 below
    are held:

 

	 	 

 

	 	(c)	Full
    Legal Name of Natural Control Person (which means a natural person who directly or indirectly alone or with others has power
    to vote or dispose of the securities covered by the questionnaire):

 

	 	 

 

	2.	Address
                                         for Notices to Selling Stockholder:

 

	 	 
	 	 
	 	 

 

	 	Telephone:	 
	 	Fax:	 
	 	Contact Person:	 
	 	E-mail address of Contact Person: 	 

 

	3.	Beneficial
                                         Ownership of Registrable Securities:

 

	 	(a)	Type
    and Number of Registrable Securities beneficially owned:

 

	 	 
	 	 
	 	 

 

	 	(b)	Number
    of shares of Common Stock to be registered pursuant to this Notice for resale:

 

	 	 
	 	 
	 	 

 

    	 

    	 

    

 

	4.	Broker-Dealer
                                         Status:

 

	 	(a)	Are
    you a broker-dealer?

 

	 	Yes
    [  ]	No
    [  ]

 

	 	(b)	If “yes” to Section
4(a), did you receive your Registrable Securities as compensation for investment banking services to the Company?

 

	 	Yes
[  ]	No
[  ]

 

	 	Note:	If
    no, the Commission’s staff has indicated that you should be identified as an underwriter in the Registration Statement.

 

	 	(c)	Are
    you an affiliate of a broker-dealer?

 

	 	Yes
    [  ]	No
[  ]

 

	 	Note:	If
    yes, provide a narrative explanation below:

 

	 	 

 

	 	(d)	If
    you are an affiliate of a broker-dealer, do you certify that you bought the Registrable Securities in the ordinary course
    of business, and at the time of the purchase of the Registrable Securities to be resold, you had no agreements or understandings,
    directly or indirectly, with any person to distribute the Registrable Securities?

 

	 	Yes
[  ]	No
[  ]

 

	 	Note:	If
    no, the Commission’s staff has indicated that you should be identified as an underwriter in the Registration Statement.

 

    	 

    	 

    

 

	5.
    	Beneficial
    Ownership of Other Securities of the Company Owned by the Selling Stockholder.

 

Except
as set forth below in this Item 5, the undersigned is not the beneficial or registered owner of any securities of the Company
other than the Registrable Securities listed above in Item 3.

 

		Type
                                         and amount of other securities beneficially owned:
	 	 
		 
		 

 

	6.
    	Relationships
    with the Company:

 

Except
as set forth below, neither the undersigned nor any of its affiliates, officers, directors or principal equity holders (owners
of 5% of more of the equity securities of the undersigned) has held any position or office or has had any other material relationship
with the Company (or its predecessors or affiliates) during the past three years.

 

		State
                                         any exceptions here:
	 	 
		 
		 

 

	7.
    	Plan
    of Distribution:

 

The undersigned
has reviewed the form of Plan of Distribution attached as Exhibit A to the Agreement, and hereby confirms that, except as set
forth below, the information contained therein regarding the undersigned and its plan of distribution is correct and complete.

 

		State
                                         any exceptions here:
		 
		 

 

***********

 

The
undersigned agrees to promptly notify the Company of any inaccuracies or changes in the information provided herein that may occur
subsequent to the date hereof and prior to the effective date of any applicable Resale Registration Statement. All notices hereunder
shall be made in writing, by hand delivery, confirmed or facsimile transmission, first-class mail or air courier guaranteeing
overnight delivery at the address set forth below. In the absence of any such notification, the Company shall be entitled to continue
to rely on the accuracy of the information in this Notice and Questionnaire.

 

    	 

    	 

    

 

By
signing below, the undersigned consents to the disclosure of the information contained herein in its answers to Items (1) through
(7) above and the inclusion of such information in the Resale Registration Statement and the Prospectus. The undersigned understands
that such information will be relied upon by the Company in connection with the preparation or amendment of any such Registration
Statement and the Prospectus.

 

By
signing below, the undersigned acknowledges that it understands its obligation to comply, and agrees that it will comply, with
the provisions of the Exchange Act and the rules and regulations thereunder, particularly Regulation M in connection with any
offering of Registrable Securities pursuant to the Resale Registration Statement. The undersigned also acknowledges that it understands
that the answers to this Questionnaire are furnished for use in connection with Registration Statements filed pursuant to the
Agreement and any amendments or supplements thereto filed with the Commission pursuant to the Securities Act.

 

The
undersigned hereby acknowledges and is advised of the following Interpretation A.65 of the July 1997 SEC Manual of Publicly Available
Telephone Interpretations regarding short selling:

 

“An
Issuer filed a Form S-3 registration statement for a secondary offering of common stock which is not yet effective. One of the
selling stockholders wanted to do a short sale of common stock “against the box” and cover the short sale with registered
shares after the effective date. The issuer was advised that the short sale could not be made before the registration statement
become effective, because the shares underlying the short sale are deemed to be sold at the time such sale is made. There would,
therefore, be a violation of Section 5 if the shares were effectively sold prior to the effective date.”

 

By returning
this Questionnaire, the undersigned will be deemed to be aware of the foregoing interpretation.

 

I confirm
that, to the best of my knowledge and belief, the foregoing statements (including without limitation the answers to this Questionnaire)
are correct.

 

IN WITNESS
WHEREOF the undersigned, by authority duly given, has caused this Questionnaire to be executed and delivered either in person
or by its duly authorized agent.

 

	Dated:	 	 	Beneficial Owner:	 
	 	 	 	 	 
	 	 	 	By:	 
	 	 	 	Name:	 
	 	 	 	Title:

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00239-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00239-of-00352.parquet"}]]